Impact of supplemental vitamins and natural honey for treatment of COVID-19: A review
Braz. J. Pharm. Sci. (Online)
; 58: e20607, 2022. tab, graf
Article
in English
| WHO COVID, LILACS (Americas) | ID: covidwho-2197574
Responsible library:
BR1.1
ABSTRACT
Abstract The main aim of the paper is to assess whether vitamin C, vitamin D, and natural honey can be administered in the course of the COVID-19 pandemic for promising in line methods with recent evidence. Both systematic literature and clinical trial identification were conducted by searching various databases. A total 58 articles and 29 clinical trials were selected wherein 11 for vitamin C, 16 for vitamin D, and 2 for natural honey were identified for analysis. The high doses of vitamin C (i.e. '200 mg/kg body weight/day, divided into 4 doses') has been found to reduce COVID-19 lung damage, various flu infections. Additionally, the high doses of vitamin C can shorten around 7.8% stay in the intensive care unit. At the same time, vitamin D can effectively protect from lung injury and acute respiratory infections whereas vitamin D deficiency severely affects 75% of the institutionalized people (serum 25(OH) D < 25 nmol/L). Meanwhile, natural honey which contains proteins (0.1-0.4%); ash (0.2%); water (15-17%) has potential antiviral effects and the ability to improve immunity. Therefore, the administration of vitamins and honey is the promising evidence-based approach for reducing fatalities, saving lives, and bringing the COVID-19 pandemic to a rapid end. It is believed that the utilization of vitamin C, vitamin D, and natural honey with the current treatment may be effective in treating COVID-19-caused fatal complications such as pneumonia. Therefore, high-level clinical studies are required on COVID-19 to administrate the effects of vitamins and natural honey.
Full text:
Available
Collection:
International databases
Database:
WHO COVID
/
LILACS (Americas)
Type of study:
Experimental Studies
/
Prognostic study
/
Randomized controlled trials
/
Systematic review/Meta Analysis
Language:
English
Journal:
Braz. J. Pharm. Sci. (Online)
Journal subject:
Farmacologia
/
Teraputica
/
Toxicologia
Year:
2022
Document Type:
Article
Institution/Affiliation country:
Bangladesh Health Professions Institute/BD
/
Dhaka Medical College Hospital/BD
/
Islamic University of Technology/BD
/
Military Institute of Science and Technology/BD
/
The Ibn Sina Pharmaceutical Industry Ltd/BD
/
Universiti Putra Malaysia/MY
Similar
MEDLINE
...
LILACS
LIS